Related Experiment Videos
[Somatostatin -- a review (author's transl)]
Klinische Wochenschrift
|April 1, 1976
Summary
Somatostatin, a peptide hormone, inhibits growth hormone release. It also impacts the secretion of other hormones like TSH, insulin, and glucagon.
Area of Science:
- Endocrinology
- Neuroendocrinology
- Molecular Biology
Background:
- Somatostatin is a peptide hormone originating from the hypothalamus.
- Its role in regulating endocrine functions is of significant interest.
Purpose of the Study:
- To investigate the inhibitory effects of somatostatin on hormone secretion.
- To explore the broad impact of somatostatin on the endocrine system.
Main Methods:
- In vivo and in vitro experimental models were utilized.
- Hormone levels were measured following somatostatin administration.
Main Results:
- Somatostatin effectively prevented growth hormone secretion.
- The secretion of thyroid-stimulating hormone (TSH), insulin, glucagon, gastrin, vasoactive intestinal peptide (VIP), and gastric inhibitory peptide (GIP) was interfered with by somatostatin.
- A blunting effect on prolactin and adrenocorticotropic hormone (ACTH) secretion was observed under specific conditions.
Conclusions:
- Somatostatin is a potent inhibitor of growth hormone secretion.
- Somatostatin exhibits widespread inhibitory effects on the secretion of multiple pituitary and pancreatic hormones.
- Further research may elucidate the therapeutic potential of somatostatin in conditions involving hormonal excess.